NYSE - Nasdaq Real Time Price USD
Perrigo Company plc (PRGO)
27.09
+0.92
+(3.52%)
As of 12:45:50 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 5 | 5 |
| Avg. Estimate | 0.59 | 0.79 | 3.03 | 3.26 |
| Low Estimate | 0.55 | 0.75 | 3 | 3.21 |
| High Estimate | 0.62 | 0.82 | 3.06 | 3.31 |
| Year Ago EPS | 0.53 | 0.81 | 2.57 | 3.03 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | 1.08B | 1.11B | 4.43B | 4.52B |
| Low Estimate | 1.07B | 1.1B | 4.38B | 4.47B |
| High Estimate | 1.09B | 1.12B | 4.45B | 4.58B |
| Year Ago Sales | 1.07B | 1.09B | 4.37B | 4.43B |
| Sales Growth (year/est) | 1.62% | 2.37% | 1.20% | 2.17% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 0.46 | 0.81 | 0.92 | 0.57 |
| EPS Actual | 0.53 | 0.81 | 0.93 | 0.6 |
| Difference | 0.07 | -0 | 0.01 | 0.03 |
| Surprise % | 16.04% | -0.24% | 0.93% | 6.05% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.59 | 0.79 | 3.03 | 3.26 |
| 7 Days Ago | 0.59 | 0.8 | 3.02 | 3.26 |
| 30 Days Ago | 0.62 | 0.8 | 2.99 | 3.24 |
| 60 Days Ago | 0.64 | 0.79 | 2.97 | 3.16 |
| 90 Days Ago | 0.78 | 0.81 | 2.99 | 3.32 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 2 | 2 |
| Up Last 30 Days | -- | 1 | 3 | 3 |
| Down Last 7 Days | 3 | 1 | 2 | 2 |
| Down Last 30 Days | 3 | 1 | 2 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PRGO | 12.05% | -2.70% | 18.02% | 7.62% |
| S&P 500 | 13.13% | 2.45% | 7.54% | 14.08% |
Upgrades & Downgrades
| Downgrade | Piper Sandler: Overweight to Neutral | 1/6/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 9/30/2024 |
| Downgrade | Jefferies: Buy to Hold | 9/23/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 7/11/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 6/13/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 4/12/2024 |
Related Tickers
KMDA Kamada Ltd.
7.00
+0.43%
GRUSF Grown Rogue International Inc.
0.3390
-3.14%
CPIX Cumberland Pharmaceuticals Inc.
5.62
-4.58%
LFCR Lifecore Biomedical, Inc.
6.91
+1.92%
ELAN Elanco Animal Health Incorporated
14.18
+1.91%
VTRS Viatris Inc.
9.03
+2.44%
TAK Takeda Pharmaceutical Company Limited
15.24
+1.87%
UTHR United Therapeutics Corporation
277.27
-15.57%
DVAX Dynavax Technologies Corporation
10.30
+0.15%
TEVA.TA Teva Pharmaceutical Industries Limited
6,332.00
+0.81%